Cyclacel Pharmaceuticals Inc reports results for the quarter ended September 30 - Earnings Summary

Bio Green Med Solution

13/11/2024 24:06

* Cyclacel Pharmaceuticals Inc  CYCC.OQ  reported a
quarterly
adjusted loss of 18 cents​​ per share for the quarter ended
September 30, higher than the same quarter last year, when the
company reported EPS of $-7.35.  The mean expectation of
two analysts for the quarter was for a loss of 56 cents per
share. Wall Street expected results to range from -57 cents
to -54 cents per share.
    * Revenue fell 37.5% to $10.00 thousand from a year ago;
analysts
expected $5.00 thousand. 
    * Cyclacel Pharmaceuticals Inc's reported EPS for the
quarter was
a loss of 18 cents​.
    * The company reported a quarterly loss of $1.96 million.
    * Cyclacel Pharmaceuticals Inc shares had fallen by 54.6%
this
quarter and lost 83.2% so far this year.

FORECAST CHANGES
    * The mean earnings estimate of analysts had risen by
about 49.5%
in the last three months.​ 
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company.

RECOMMENDATIONS
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 1 "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell." 
    * The average consensus recommendation for the biotechnology
&
medical research peer group is also "buy"

Wall Street's median 12-month price target for Cyclacel
Pharmaceuticals Inc is 6.00 
This summary was machine generated from LSEG data November 13 at
12:06 a.m. UTC. ​All figures in US dollars unless otherwise
stated. (For questions concerning the data in this report,
contact Estimates.Support@lseg.com. For any other questions or
feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Sep. 30 2024      -0.55          -0.18          Beat
 Jun. 30 2024      -1.43          -0.72          Beat
 Mar. 31 2024      -4.74          -2.27          Beat
 Dec. 31 2023      -5.89          -6.23          Missed